While the overall survival benefit did not reach statistical significance, subgroup analyses showed possible interactions with squamous histology and programmed death-ligand 1 (PD-L1) positivity.
← all excerpts
ESMO podcast on upper gastrointestinal cancers-highlights in esophagogastric cancers from ASCO 2025.
1
—
—